Prolacta Bioscience

The Philip et al. study explores how human milk fortifiers contribute additional bioactive components to the nutrition provided to extremely low birth weight (ELBW) infants. To review the research, access the publication here: hubs.li/Q0482Tvd0

Day 1 of the GFCNI Parent & Patient Organizations Summit kicked off with a welcome from Cristal Grogan and Sven Maenhout, highlighting why parent consent is essential in ensuring families have a real voice in newborn care. #GFCNI #ParentAdvocacy

Sarah welcomed baby Parker at 28 weeks, weighing 2 lbs 6.5 oz. After 78 days in the NICU & using Prolacta fortifiers, Parker went home 5 inches taller and 5 lbs heavier! Read their story: hubs.li/Q047xzyT0 #ExtremelyPremature #NICUNutrition #HumanMilkFortifier

Prolacta is attending the National Perinatal Association’s 2026 Interdisciplinary Conference, Uniting for Impact, held March 25–27. We look forward to connecting with perinatal leaders and discussing ways to improve outcomes for fragile infants. #NPA2026

This study compares NEC incidence and associated mortality in preterm infants fed an Exclusive Human Milk Diet (EHMD) versus a bovine-based diet, with meaningful implications for NICU feeding practices. hubs.li/Q046GFZ70 #NICUNutrition #Neonatology #HumanMilkScience #EHMD

Meet Kayla, a NICU nurse and mom to preemie Elliott, who weighed just 2 lbs 15 oz at birth. Her journey with Prolacta and generous breastmilk donations has helped countless NICU babies thrive. Read her story: hubs.li/Q045x-bj0 #NICUNurse #BreastmilkDonation

March is Nutrition Awareness Month, a time to recognize the role 100% human milk-based fortifier plays in improving outcomes for medically fragile and extremely premature infants. #NutritionAwarenessMonth #NICUNutrition #Neonatology #HumanMilkScience #PreemieHealth

Prolacta is proud to support the GFCNI Parent & Patient Organizations Summit, uniting families and advocates dedicated to improving outcomes for critically ill and premature infants. Honored to stand with those championing the best start for every baby. #GFCNI #ParentSummit

Day 1 at NEO is underway! Our team is excited to join neonatology leaders committed to advancing newborn care. From new research to clinical insights, we’re here to support the tiniest patients and connect with the clinicians shaping their future. #NEO2026

Japan’s Ministry of Health, Labour and Welfare approved Prolacta’s 100% human milk-based fortifier as a prescription drug underscoring human milk-based fortification’s essential role in neonatal care. Read More: hubs.li/Q043Z1vT0 #NeonatalCare #HumanMilkScience

Prolacta’s free “Health Complications Have Costs” resource highlights how nutrition choices impact outcomes and costs for VLBW infants, including the 57.5‑day average NICU stay and the role of an EHMD in reducing complications. hubs.li/Q043J0Nb0

Japan’s Ministry of Health, Labour and Welfare has approved Prolacta’s 100% human milk‑based fortifier as a prescription drug for vulnerable infants, our first pharmaceutical product approval. Read more: hubs.li/Q043HLWY0 #NeonatalCare #HumanMilkScience

Early nutrition plays a powerful role in supporting medically fragile and VLBW infants. Human milk–based nutrition can help reduce complications, support growth, and strengthen clinical trajectories from the start. hubs.li/Q043qtq60 #NICUNutrition #HumanMilkScience

Prolacta is excited to join NEO: The Conference for Neonatology, connecting with clinicians dedicated to advancing newborn care. We’re committed to supporting improved outcomes for critically ill and extremely premature infants through human milk–based nutrition.

The SMFM Pregnancy Meeting is here! Prolacta looks forward to connecting with maternal–fetal medicine leaders to share guidance on preparing high-risk pregnancy patients with information on NICU nutrition. #SMFM2026

Prolacta is excited to attend ASPEN 2026 in Long Beach! We’re committed to advancing evidence‑based neonatal nutrition and improving outcomes for critically ill and extremely premature infants through human milk–based nutrition. See you at #ASPEN26.

Research by Gulustan Ozturk et al explores how thermal processing and homogenization affect human milk fat globule (MFG) properties, with important implications for milk's bioactivity and digestibility. hubs.li/Q0425DfT0 #HumanMilkResearch #InfantNutrition

Proud to join the National Black Nurses Association for NBNA Capitol Hill Day 2026. Prolacta is committed to supporting equitable care and improving outcomes for critically ill and premature infants through human milk–based nutrition. #NBNA #CapitolHillDay #HealthEquity

Prolacta proudly supports the 38th National Black Nurses Day on Capitol Hill, celebrating Black nurses’ leadership and their advocacy for health equity. Learn more: hubs.li/Q03_hg8t0 #NationalBlackNursesDay #HealthEquity

Peer-reviewed evidence continues to show that 100% human milk–based fortification supports improved outcomes for extremely premature infants. · Reduced complications · Improved growth · Lower total cost of care Learn more: hubs.li/Q03-Mb4D0